Tech Company Financing Transactions
Peel Therapeutics Funding Round
Peel Therapeutics closed a $9 million Seed funding round on 2/23/2023. Backers included private investors.
Transaction Overview
Company Name
Announced On
2/23/2023
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance clinical and pre-clinical programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
630 South Komas Dr 300
Salt Lake City, UT 84108
USA
Salt Lake City, UT 84108
USA
Phone
Undisclosed
Website
Email Address
Overview
Peel Therapeutics is on an expedition to unlock nature's secrets and overcome life-threatening conditions. These evolutionary outliers rarely make their way to patients, and we are determined to change that. We are an evolutionary-inspired, clinical-stage biotech company developing medicines to transform patients' lives. Peel (the Hebrew word for "elephant") launched with our focus on cancer-fighting proteins in elephants and we quickly recognized the power of using evolution's solutions to treat and prevent disease. In addition to developing elephant p53 (EP53) nanoparticles for the treatment of cancer, our team is advancing additional therapies derived from nature's superabilities to treat cancer and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Schiffman
Chief Financial Officer
Jim Levison
VP - Operations
Trent Fowler
Browse more venture capital transactions:
Prev: 2/23/2023: OnePulse venture capital transaction
Next: 2/23/2023: Sprout venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs